05/04/2024
We are excited to announce an industry first collaboration between EyRIS and us, Ophhtalmic Instruments!
We recently signed the Memorandum of Understanding (MOU) with EyRis, which set the stage for our innovative partnership, aiming at revolutionizing healthcare services throughout Singapore and Malaysia.
With this partnership, EyRIS and Ophthalmic Instruments will be combining our expertise to introduce HAS approved EyRIS’s advanced SELENA+ algorithm to the market. This advanced algorithm enhances the accessibility of diabetic retinopathy (DR) screening, with the aid of Artificial Intelligence.
This initiative offers state-of-the-art service uptake with hardware for as low as S$600 per month, while offering seamless workflow that will see transfer of cases to Singapore National Eye Center (SNEC) Ocular Reading Centre for secondary grading. We believe that this package will not only streamline the process of healthcare professionals, while significantly lowering the entry point to such services in various clinics, benefiting patients in need for early detection and treatment.
In addition, this collaboration will see us distributing EyRIS’s fully autonomous fundus camera FC162, which offers 50 degrees field of view fundus imaging with the need for an operator. FC162 also seamlessly integrates with EyRIS’s platform, EySCAN, further reducing the need for downloading and uploading of images between the fundus camera and our software.
EyRIS excels in development and deployment of AI Deep Learning System (DLS) in the healthcare industry. DLS is a breakthrough machine in learning technology, utilizing representation-learning methods with multiple levels of representation to process natural data in their raw form, recognizing the intricate structure in high-dimensional data. Their first DLS solution performs automated image analysis for eye diseases such as diabetes retinopathy, with add-ons for glaucoma and age-related macular degeneration.
With our partnership with EyRIS, we aim to transfigure the delivery of healthcare through AI-powered solutions, with the ultimate goal of leading the industry for first-stage medical diagnostics.
Please WhatApp us on +65 8584 9422 for an appointment now!